Journal article
Rationale and design of the iPap trial: A randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia
F Sultana, DR English, JA Simpson, JML Brotherton, K Drennan, R Mullins, S Heley, CD Wrede, M Saville, DM Gertig
BMC Cancer | Published : 2014
Abstract
Background: Organized screening based on Pap tests has substantially reduced deaths from cervical cancer in many countries, including Australia. However, the impact of the program depends upon the degree to which women participate. A new method of screening, testing for human papillomavirus (HPV) DNA to detect the virus that causes cervical cancer, has recently become available. Because women can collect their own samples for this test at home, it has the potential to overcome some of the barriers to Pap tests. The iPap trial will evaluate whether mailing an HPV self-sampling kit increases participation by never- and under-screened women within a cervical screening program.Methods/Design: Th..
View full abstractGrants
Awarded by Roche
Funding Acknowledgements
This study is funded by National Health and Medical Research Council Project Grant, Grant no: APP1045346. FS is supported by the Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education (DIICCSRTE), Australia through its Australia Awards Endeavour Scholarships and Fellowships scheme. We also thank the Information technology department of VCCR for development of the iPap database for the study. We thank Michael Murphy & Michelle Scuderi of Michael Murphy Research for conducting the focus groups. We also thank the participants of the focus groups for their input in finalising the letters and the educational materials for the trial.